Millennium Management »

Oncternal Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Oncternal Therapeutics (ONCT) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Oncternal Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oncternal Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncternal Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $782k 103k 7.60
2024-03-31 $928k 103k 9.00

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Put Option (MSFT)
Amazon Put Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors (TSLA)
Broadcom Put Option (AVGO)
Ishares Tr Msci Emg Mkt Etf (EEM)
Advanced Micro Devices Put Option (AMD)
Merck & Co Call Option (MRK)

View all positions for Millennium Management

Top funds holding Oncternal Therapeutics

Vanguard Group
Millennium Management
BlackRock
Dimensional Fund Advisors
Geode Capital Management
Pasadena Private Wealth
Richmond Brothers
Renaissance Technologies
Susquehanna International
Morgan Stanley
Quantum Private Wealth
Acadian Asset Management
Jpmorgan Chase & Co
Tower Research Capital
Wells Fargo & Company

View all funds holding Oncternal Therapeutics